Back to BIIB

BIOGEN INC. Share-Based Compensation 2007-2026 | BIIB

Beta

What is share-based compensation?

Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.

What is BIOGEN INC.'s current share-based compensation?

BIOGEN INC. (BIIB) annual share-based compensation for 2025 was $290.8M, a 0.14% decline from 2024. BIOGEN INC. share-based compensation for the quarter ending March 31, 2026 was $84.0M.

What was BIOGEN INC.'s share-based compensation in 2024?

BIOGEN INC. annual share-based compensation for 2024 was $291.2M, a 10.22% increase from 2023.

What was BIOGEN INC.'s share-based compensation in 2023?

BIOGEN INC. annual share-based compensation for 2023 was $264.2M, a 3.97% increase from 2022.

What is BIOGEN INC.'s 5-year share-based compensation CAGR?

BIOGEN INC. share-based compensation grew at a compound annual growth rate (CAGR) of 7.96% from FY2020 to FY2025, going from $198.3M to $290.8M over 5 years.

Share-Based Compensation History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+8.0%
FY2020
$198.3M
→
FY2025
$290.8M
07080910111213141516171819202122232425
5 years selected
Share-Based Compensation History
PeriodValueChangeSource
FY2025$290.8M-0.1%10-K
FY2024$291.2M+10.2%10-K
FY2023$264.2M+4.0%10-K
FY2022$254.1M+6.5%10-K
FY2021$238.6M+20.3%10-K
FY2020$198.3M+8.8%10-K
FY2019$182.3M+15.7%10-K
FY2018$157.5M+23.0%10-K
FY2017$128.0M-17.3%10-K
FY2016$154.8M-4.1%10-K
FY2015$161.4M+3.9%10-K
FY2014$155.3M+13.9%10-K
FY2013$136.3M+15.0%10-K
FY2012$118.6M+4.9%10-K
FY2011$113.0M-32.7%10-K
FY2010$167.8M+4.3%10-K
FY2009$160.9M+10.1%10-K
FY2008$146.2M+18.7%10-K
FY2007$123.1M-10-K
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →